ABT

The healthcare industry remains stressed despite a marked improvement in the pandemic situation, with patient visits increasing steadily and elective…

Abbott Laboratories (NYSE: ABT) Q3 2021 Earnings Conference

Abbott Laboratories (NYSE: ABT) Q2 2021 earnings call dated Jul. 22, 2021 Corporate Participants: Scott Leinenweber — Vice President of Investor Relations,…

Abbott Laboratories (NYSE: ABT) Q2 2021 Earnings Conference

Abbott Laboratories (NYSE: ABT) Q1 2021 earnings call dated Apr. 20, 2021 Corporate Participants: Scott Michael Leinenweber — Vice President of Investor…

Abbott Laboratories (NYSE: ABT) reported first quarter 2021 earnings results today. Sales increased 35.3% year-over-year to $10.5 billion. On an…

Abbott (NYSE: ABT) Q1 2021 Earnings Conference

The financial performance of Abbott Laboratories (NYSE: ABT) has been positively impacted by the high demand for COVID-related diagnostic services.…

Abbott Laboratories (NYSE: ABT) Q4 2020 earnings call dated Jan. 27, 2021. Corporate Participants: Scott Leinenweber — Vice President, Investor Relations, Licensing and…

Abbott Laboratories (NYSE: ABT) Q4 2020 earnings call dated Jan. 27, 2021. Corporate Participants: Scott Leinenweber — Vice President, Investor Relations, Licensing…